Complementing this information, a recent study with 715 samples of patients with breast cancer have shown that high protein levels of nuclear DYRK2 were associated with significantly reduced cancer survival and a shorter time to recurrence specifically within the TNBC subtype cohort (11). Here, DYRK2 is linked to breast carcinoma.